TY - JOUR
T1 - Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk
AU - Campa, Daniele
AU - McKay, James
AU - Sinilnikova, Olga
AU - Hüsing, Anika
AU - Vogel, Ulla
AU - Hansen, Rikke Dalgaard
AU - Overvad, Kim
AU - Witt, Petra Mariann
AU - Clavel-Chapelon, Françoise
AU - Boutron-Ruault, Marie Christine
AU - Chajes, Veronique
AU - Rohrmann, Sabine
AU - Chang-Claude, Jenny
AU - Boeing, Heiner
AU - Fisher, Eva
AU - Trichopoulou, Antonia
AU - Trichopoulos, Dimitrios
AU - Palli, Domenico
AU - Villarini, Anna
AU - Sacerdote, Carlotta
AU - Mattiello, Amalia
AU - Tumino, Rosario
AU - Peeters, Petra H.M.
AU - Van Gils, Carla H.
AU - Bas Bueno-De-Mesquita, H.
AU - Lund, Eiliv
AU - Chirlaque, María Dolores
AU - Sala, Núria
AU - Suarez, Laudina Rodriguez
AU - Barricarte, Aurelio
AU - Dorronsoro, Miren
AU - Sánchez, Maria José
AU - Lenner, Per
AU - Hallmans, Göran
AU - Tsilidis, Kostas
AU - Bingham, Sheila
AU - Khaw, Kay Tee
AU - Gallo, Valentina
AU - Norat, Teresa
AU - Riboli, Elio
AU - Rinaldi, Sabina
AU - Lenoir, Gilbert
AU - Tavtigian, Sean V.
AU - Canzian, Federico
AU - Kaaks, Rudolf
PY - 2009/12
Y1 - 2009/12
N2 - Fatty acid synthase (FAS) is the major enzyme of lipogenesis. It catalyzes the NADPH-dependent condensation of acetyl-CoA and malonyl-CoA to produce palmitic acid. Transcription of the FAS gene is controlled synergistically by the transcription factors ChREBP (carbohydrate response element-binding protein), which is induced by glucose, and SREBP-1 (sterol response element-binding protein-1), which is stimulated by insulin through the PI3K/Akt signal transduction pathway. We investigated whether the genetic variability of the genes encoding for ChREBP, SREBP and FAS (respectively, MLXIPL, SREBF1 and FASN) is related to breast cancer risk and body-mass index (BMI) by studying 1,294 breast cancer cases and 2,452 controls from the European Prospective Investigation on Cancer (EPIC). We resequenced the FAS gene and combined information of SNPs found by resequencing and SNPs from public databases. Using a tagging approach and selecting 20 SNPs, we covered all the common genetic variation of these genes. In this study we were not able to find any statistically significant association between the SNPs in the FAS, ChREBP and SREPB-1 genes and an increased risk of breast cancer overall and by subgroups of age, menopausal status, hormone replacement therapy (HRT) use or BMI. On the other hand, we found that two SNPs in FASN were associated with BMI.
AB - Fatty acid synthase (FAS) is the major enzyme of lipogenesis. It catalyzes the NADPH-dependent condensation of acetyl-CoA and malonyl-CoA to produce palmitic acid. Transcription of the FAS gene is controlled synergistically by the transcription factors ChREBP (carbohydrate response element-binding protein), which is induced by glucose, and SREBP-1 (sterol response element-binding protein-1), which is stimulated by insulin through the PI3K/Akt signal transduction pathway. We investigated whether the genetic variability of the genes encoding for ChREBP, SREBP and FAS (respectively, MLXIPL, SREBF1 and FASN) is related to breast cancer risk and body-mass index (BMI) by studying 1,294 breast cancer cases and 2,452 controls from the European Prospective Investigation on Cancer (EPIC). We resequenced the FAS gene and combined information of SNPs found by resequencing and SNPs from public databases. Using a tagging approach and selecting 20 SNPs, we covered all the common genetic variation of these genes. In this study we were not able to find any statistically significant association between the SNPs in the FAS, ChREBP and SREPB-1 genes and an increased risk of breast cancer overall and by subgroups of age, menopausal status, hormone replacement therapy (HRT) use or BMI. On the other hand, we found that two SNPs in FASN were associated with BMI.
KW - Body-mass index
KW - Breast cancer
KW - Carbohydrate response element-binding protein
KW - Fatty acid synthase
KW - Sterol response element-binding protein-1
KW - Susceptibility to cancer
UR - http://www.scopus.com/inward/record.url?scp=70449589347&partnerID=8YFLogxK
U2 - 10.1007/s10549-009-0347-8
DO - 10.1007/s10549-009-0347-8
M3 - Article
SN - 0167-6806
VL - 118
SP - 565
EP - 574
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
IS - 3
ER -